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Abstract The Escherichia coli L-galactosidase is a high
molecular mass tetrameric enzyme extensively used as a
molecular marker. Despite its proven utility as a partner in
fusion proteins, previous attempts to generate insertional mutants
rendered inactive or poorly active enzymes, hampering its further
engineering for the construction of multifunctional enzymes. We
have explored several solvent-exposed loops on the tetramer,
namely those spanning residues 246^254, 271^287, 578^584,
770^773, and 793^806, as acceptor sites to accommodate
functional protein segments on the surface of active L-
galactosidase enzymes. An RGD-containing antigenic peptide
positioned in these sites interacts efficiently with specific
monoclonal antibodies as well as target integrins on the surface
of mammalian cells. The resulting chimeric enzymes are soluble,
stable, produced in high yields and enzymatically active. More-
over, the identified insertion sites could be appropriated for the
design of promising L-galactosidase-based molecular sensors.
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1. Introduction
The L-galactosidase enzyme (EC 3.2.1.23) encoded by the
Escherichia coli lacZ gene, is a high molecular mass multi-
meric protein composed of four non-covalently linked sub-
units. This enzyme hydrolyses lactose into glucose and galac-
tose, allowing this sugar to be used as a substrate for
heterotrophic bacterial growth. Although this activity has
been exploited in food industry to remove lactose from dairy
products, the widest application of this enzyme is as a reporter
protein or molecular sensor in microbiology and molecular
and cell biology. This use has been stimulated by the ability
of L-galactosidase to hydrolyse lactose analogues such as or-
tho-nitrophenyl-L-D-galactopyranoside (ONPG), chlorophenol
red galactopyranoside (CPRG) and 5-bromo-4-chloro-3-in-
dolyl-L-D-galactopyranoside (X-gal), rendering coloured com-
ponents that can be either spectrophotometrically quanti¢ed
or visualised in situ. In addition, the development of rapid
and simple enzymatic assays [1] has extended the use of
lacZ (or a 5P gene segment, encoding the a-complementing
L-galactosidase domain) as a universal reporter gene in both
prokaryotic and eukaryotic cells.
Although the C-terminus of L-galactosidase is poorly toler-
ant to protein fusions [2,3], the N-terminus can accept large
proteins or protein domains without signi¢cant loss of activity
[4]. For this reason, this enzyme has also been exploited as a
molecular carrier to stabilise heterologous proteins produced
in bacteria [5,6], and also to provide either monitoring [7,8] or
puri¢cation tags [9] for production and downstream processes.
More recently, the engineering of L-galactosidase has resulted
in the generation of molecular tools for a diversity of pur-
poses. For some of these uses an essential requirement is the
insertion of foreign peptides into permissive, solvent-exposed
sites, rendering stable chimeric enzymes. As a result of peptide
insertions done randomly (or according to structural predic-
tions) along the sequence of L-galactosidase, unstable or ex-
tremely poorly active proteins have been generated [10,11].
However, the X-ray structure of the E. coli L-galactosidase
[12] o¡ers a rationale to explore new candidate peptide accept-
or sites. In this work, we have inserted a heterologous protein
segment in several solvent-exposed loops of the E. coli L-gal-
actosidase to estimate their reactivity and functionality once
positioned and the stability and activity of the resulting chi-
meric enzymes. While the obtained results show a critical role
of solvent-exposed loops in the enzyme structure, permissive
sites for insertions of functional enzymes have been identi¢ed.
2. Material and methods
2.1. Plasmids and bacterial strains
The pJXxxxA series is a collection of vectors derived from pJLACZ
[13] encoding modi¢ed L-galactosidases. A peptide, reproducing the
amino acid sequence (amino acids 134^156) of the FMDV VP1 G-H
loop (isolate C-Sta. Pau, Spain/70, clone C-S8c1, serotype C) [14], has
been inserted at speci¢c residues whose position is indicated by plas-
mid reference numbers. BamHI restriction sites were introduced at the
desired sites of lacZ gene in the plasmid pJLACZ by using appropri-
ate oligonucleotide primers and PCR ampli¢cation as described [15].
In these sites we introduced the 70-bp BamHI-BamHI DNA fragment
from plasmid pM275VP1, which encodes the VP1 G-H loop segment.
For the construction of pJX8CA, pJLACZ was digested with EcoRI,
the resulting ends ¢lled in with Klenow and the vector ligated with a
PCR-ampli¢ed segment also encoding the G-H loop sequence. The
amino acid sequence at the acceptor sites is depicted in Fig. 1. Plas-
mids pJLACZ, pM275VP1 and pMV278VP1 have been previously
described [13,15]. The expression of the engineered lacZ genes is under
the control of the CI857ts-repressed pRpL lambda promoters [16]. All
the constructs were transformed into the E. coli strain MC1061,
hsdR2, mcrB, araD139, v(araABC-leu) lacX74, vlacX74, galU, galK,
rpsL, thi, strA [17], and the proteins produced by temperature shift in
the strain BL26, a Lac3 derivative of BL21, hsdS gal Lon3 OmpT3
[18].
2.2. Bacterial growth and production of recombinant L-galactosidases
Bacterial cultures were grown in 200 ml of LB medium [19], plus
100 Wg/ml ampicillin and 50 Wg/ml streptomycin (when required), in 1-
liter shaker £asks, at 32‡C and 250 rpm. When the OD550 reached
between 0.3 and 0.4 units, the cultures were transferred to a pre-
warmed bath at 42‡C, and further incubated under the same condi-
tions, until steady values of L-galactosidase activity were observed.
Then cells were harvested by centrifugation and pellets resuspended
in 10 ml of 50 mM Tris-HCl, 10 mM MgCl2, 100 mM NaCl and 10
mM L-mercaptoethanol, pH 7.2, with benzamidine and phenylmethyl-
sulfonyl £uoride at 25 WM and 1 mM, respectively, to prevent pro-
teolysis. Cell disruption was achieved by ultrasonication as described
[20], and puri¢cation of recombinant proteins was done by a⁄nity
chromatography [9]. Brie£y, crude cell extracts were applied to a
15-ml p-aminophenyl-L-D-galactoside-Sepharose column equilibrated
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with 20 mM Tris-HCl, 10 mM MgCl2, 1.6 M NaCl, pH 7.5. After
washing until the A280 at the outlet dropped near zero, the retained
proteins were eluted with 100 mM Na2B4O7, 10 mM L-mercaptoetha-
nol, pH 10, and dialysed against 20 mM Tris-HCl, 10 mM MgCl2, pH
7.5. Then the puri¢ed enzymes were stored at 380‡C until required.
2.3. Determination of protein concentration
Puri¢ed proteins were analysed by SDS-polyacrylamide gel electro-
phoresis (PAGE) followed by either Coomassie blue staining and
immunoblotting as described [11]. Protein bands were visualised
with polyclonal serum anti-L-galactosidase. Concentration of engin-
eered L-galactosidases was determined spectrophotometrically at 280
nm. Molar absorption coe⁄cients of the mutant proteins were deter-
mined as described [21], obtaining values very similar
(A= 1.5U106 þ 1.4U105 M31 cm31) to that previously described for
E. coli L-galactosidase [22]. Other independent methods, namely nitro-
cellulose scanning followed by image analysis (with BioImage Intelli-
gent Quanti¢er software), Bradford’s colorimetric method [23] and
indirect ELISA, were also used to assess the spectrophotometric meas-
urements. Wild-type L-galactosidase (from Boehringer Mannheim)
was used as standard.
2.4. Enzymatic assay and kinetics measurements
L-Galactosidase enzymatic activity was analysed according to Mill-
er’s method [1]. One enzymatic unit is de¢ned as the amount of pro-
tein that produces 1 Wmol of o-nitrophenol per minute at 28‡C. The
speci¢c activity was calculated from samples of growing cultures with
known enzymatic activity, and the amount of protein was obtained by
densitometric analysis of Western blot sheets with appropriate stand-
ards. Km values were measured at di¡erent concentrations of substrate
(ONPG), by absorbance at 420 nm. Values of vA420/min were con-
verted to rate constants, and Km and Vmax values determined by using
the SigmaPlot Scienti¢c Graphing Software. The ¢rst-order rate con-
stant kcat (turnover number) was calculated by dividing Vmax by the
total enzyme concentration in the reaction mixture. Determinations
were performed up to ¢ve times for each protein.
2.5. Analysis of protein stability
Resistance to heat denaturation was determined by incubating pu-
ri¢ed proteins at 23 Wg/ml in bu¡er Z at 50‡C. Samples were taken at
di¡erent time intervals, immediately cooled to 4‡C and further incu-
bated at 28‡C for Miller’s assay. Puri¢ed proteins at 23 Wg/ml were
also incubated at 37‡C in bu¡er Z in the presence of 100 Wg/ml
trypsin. Aliquots were taken at di¡erent times and proteolysis was
immediately stopped with 10 WM soybean trypsin inhibitor. Enzy-
matic activity of this mixture was determined as described above in
three independent experiments. Half-lives of the active proteins under
these conditions were determined and given as t50. In vivo stability
was determined by Western blot as described [24]. Brie£y, bacterial
cultures producing the desired proteins were transferred to 37‡C im-
mediately after the addition of 100 Wg/ml chloramphenicol. Samples
were taken sequentially and ran in PAGE, immunoblotted and sub-
mitted to densitometric analysis.
2.6. Fluorescence spectroscopy
Intrinsic £uorescence was determined at 28‡C in a luminescence
spectrophotometer LS50 (Perkin Elmer) with a thermostated cell
holder, by using 15 Wg/ml-protein solutions in Z bu¡er. Quartz supra-
sil cuvettes of 10 mm light path were employed. The excitation wave-
length was set to 295 nm with a 2.5-nm slit. Emission spectra were
recorded from independent samples in triplicate, between 300 and 420
nm, with a 10-nm slit in 0.5-nm wavelength increments.
2.7. Competitive ELISA
Competitive ELISA was performed in triplicate by slight modi¢ca-
tion of a standard protocol [11]. Brie£y, 20 pmol of the KLH-coupled
synthetic peptide GH23 reproducing the inserted segment sequence
(TTYTASARGDLAHLTTTHARHLP), were adsorbed to ELISA
microtiter plates. After blocking, competition for mAb SD6 was
done as described [11] with increasing amounts of pure proteins.
2.8. Cell binding assay
Binding of chimeric proteins to baby hamster kidney (BHK) cells
was performed as previously described [25] in ELISA microtiter
plates. In each well, we adsorbed 2.5 pmol of mutant L-galactosidases
as cell ligands and 5U104 cells were added for the analysis. After 2 h
incubation at 37‡C, cell staining was done with crystal violet. The
absorbance was determined at 620 nm and the values given as referred
to that obtained by using human vitronectin as immobilised cell lig-
and.
3. Results
3.1. Design and production of chimeric L-galactosidases
A peptide of 27 amino acids, representing the G-H loop
amino acid sequence of foot-and-mouth disease virus
(FMDV) VP1 protein, has been inserted into di¡erent sites
of protein LACZ, a pseudo-wild-type E. coli L-galactosidase
lacking the 8 N-terminal amino acids. In FMDV serotype C,
this peptide contains several overlapping B-cell epitopes form-
ing the antigenic site A [26], and comprises an evolutionarily
conserved, integrin-binding RGD motif responsible for cell
attachment and infection [27]. This segment was inserted by
recombinant DNA procedures into four intra-domain, sur-
face-exposed regions without regular structure, which are
not involved in contact interfaces and are far from the neigh-
bouring domains and monomers in the folded tetramer. These
sites are distributed on di¡erent areas of the monomer surfa-
ces, and they were chosen to display the inserted peptides
separated on the assembled tetramer. The minimal distance
between insertion sites in proteins JX249A, JX581A,
JX772A and JX795A is 57 Aî , in general being higher than
90 Aî . These values were measured as the atomic distances
between the CK of the residues indicated in the protein nota-
tion. Within the loops, the precise insertion sites were selected
to generate minimal distortions, avoiding the vicinity of ami-
no acids that restrict the loop conformation, such as proline,
tyrosine and tryptophan, and looking for the proximity of
glycine that could promote more £exibility of the inserted
segment. When possible, medial sites in the target loop were
favoured. Two additional insertion proteins (M275VP1 and
M278VP1), containing the FMDV G-H loop segment posi-
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Table 1
Enzymatic properties of modi¢ed L-galactosidases
Protein Km (mM) kcat (s31) kcat/Km (mM31 s31) Speci¢c activity (U/Wg)
LACZ 0.2222 þ 0.0114 18 300 þ 436 82 345 þ 4658 2765 þ 347
JX8CA 0.2455 þ 0.0074 19 097 þ 484 77 800 þ 3065 2840 þ 218
JX249A 0.2444 þ 0.0027 15 065 þ 396 61 650 þ 1758 2030 þ 256
JX581A 0.2670 þ 0.0038 10 810 þ 269 40 490 þ 1161 960 þ 78
JX772A 0.1043 þ 0.0091 2870 þ 198 27 530 þ 3062 515 þ 31
JX795A 0.0951 þ 0.0076 2646 þ 115 27 800 þ 2529 675 þ 102
M275VP1 0.4299 þ 0.0043 2132 þ 58 4960 þ 144 375 þ 72
M278VP1 0.3100 þ 0.0970 1496 þ 173 4825 þ 1610 170 þ 43
L-Galactosidase 0.2332 þ 0.0033 19 501 þ 122 83 623 þ 1294 2950 þ 189
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tioned in the L-galactosidase activating interface [11], were
also included in this study, as well as a C-terminal fusion
which was constructed as a control. Details of all these pro-
teins are given in Fig. 1.
These chimeras were produced by temperature shift in the
E. coli strain BL26. L-Galactosidase enzymatic activity was
detected in all the cultures immediately after the expression
of the lacZ mutant genes. Inhibition of cell growth was not
observed, and the obtained yield was similar to that of paren-
tal L-galactosidase, indicating absence of toxicity over the cells
(not shown). Western blot analysis of cell extracts revealed the
presence of bands immunoreactive with both SD6 anti-VP1
monoclonal antibody (mAb) and anti-L-galactosidase sera,
with a mobility indistinguishable from that of the native L-
galactosidase (not shown). The puri¢cation of these proteins
was e⁄ciently done by p-aminophenyl-L-D-thiogalactoside
(TPEG)-Sepharose columns as described [9].
3.2. Solvent exposure of the displayed peptides
The solvent exposure of the displayed peptides on puri¢ed
proteins was assessed by competitive ELISA. All the soluble
proteins competed with a bound synthetic peptide (with the
same amino acid sequence as inserted into the enzymes) for
mAb SD6 (Fig. 2A). Since the inserted peptide also carries an
RGD motif that serves the virus to infect target cells, prob-
ably by binding to integrin aVL3 [25,28,29], cell attachment
was also explored as an indication of the steric availability
of the FMDV cell ligand motif. Fig. 2B shows signi¢cant
binding of FMDV-target cells to all the constructs.
3.3. Enzymatic activities of modi¢ed L-galactosidases
The in£uence of peptide insertions on the catalytic proper-
ties of the carrier protein is shown in Table 1. Neither the
speci¢c activity nor the speci¢city constant (kcat/Km) are al-
tered by the fusion at the C terminus, and parameters are only
moderately a¡ected by the insertion at position 249. In other
modi¢ed enzymes the viral peptide inactivates the enzyme by
at least 50%. At positions 275 and 278 the insertion a¡ects
monomer-monomer contacts in the activating interface and it
is very close to the active site. However, the enzymatic activity
of the resulting proteins is still measurable by conventional
protocols. The catalytic constant (kcat) is a¡ected in all the
modi¢ed enzymes, but an important reduction is observed in
JX772A, JX795A and especially M275VP1 and M278VP1.
However, Km increases only in M275VP1 and M278VP1,
and the speci¢city for the substrate (kcat/Km) is also dramat-
ically impaired in these two proteins. These results prove that
peptide accommodation at the tested sites, although a¡ecting
at di¡erent extent the activity of the receiving enzyme, does
not prevent either tetramer formation or substrate hydrolysis,
the latter being reduced by only 3-fold for insertions in do-
main V, and about 15-fold when the activating interface of
domain II is involved.
3.4. Structural stability of modi¢ed L-galactosidases
The peptide display at the selected sites of L-galactosidase
results in an increase of temperature and proteolytic sensitiv-
ity in vitro, in general both parameters being a¡ected simul-
taneously (Table 2). Whereas both JX8CA and JX249A are
barely less resistant to trypsin than the parental LACZ pro-
tein, the rest of the mutants are more sensitive, suggesting a
moderate destabilisation of the tetramer. However, this pro-
teolytic sensitivity was not observed in vivo (not shown). The
sensitivity to trypsin treatment of JX581A is remarkable. This
does not correspond to the high thermal stability and enzy-
matic activity exhibited by this construct. This rapid degrada-
tion appears to be caused by reasons other than loss of pro-
tein structure, since no displacement in the Wmax is observed in
the £uorescence analysis of this mutant protein. Position 278
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Table 2
Stability and tryptophan £uorescence peak of modi¢ed L-galactosidases
Protein Proteolytic stability (t50%, min) Thermal stability (t50%, min) Vmax (nm)
LACZ 109.4 þ 10.2 141.6 þ 12.7 340.75 þ 1.00
JX8CA 90.4 þ 5.4 67.5 þ 15.4 341.00 þ 0.50
JX249A 73.0 þ 3.2 11.1 þ 1.1 340.75 þ 0.75
JX581A 1.2 þ 0.1 21.8 þ 5.7 340.25 þ 0.25
JX772A 27.1 þ 3.3 18.2 þ 7.2 339.75 þ 0.50
JX795A 22.1 þ 1.6 28.7 þ 9.7 340.25 þ 0.25
M275VP1 7.0 þ 0.7 9.4 þ 0.2 341.25 þ 1.00
M278VP1 5.6 þ 0.1 8.2 þ 0.2 342.00 þ 0.25
L-Galactosidase s 270 s 240 340.50 þ 0.50
Fig. 1. Amino acid sequences at the insertion sites of the mutant L-
galactosidases (listed on the left). The inserted peptide (boxed) con-
tains 23 residues from the wild-type FMDV VP1 protein, spanning
positions 134^156 [39] (in bold), and 4 extra £anking amino acids
encoded by the BamHI restriction sites (in italics). The underlined
stretch indicates the extent of the continuous SD6 B-cell epitope
[40], and the residues labelled with asterisks are those critical for
the interaction of the whole FMDV particles with the cell surface
receptor [41]. Residues in L-galactosidase are numbered as indicated
[42], and the structure of the native enzyme is indicated by K (alpha
helices) and L (beta strands), according to published data [12]. The
L-galactosidase domain receiving the viral peptide is also indicated.
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is the only site among those tested in which peptide insertion
causes a clear although minor destabilisation of the protein
structure as monitored by shift of the £uorescence spectrum
peak.
Whereas the enzymatic activity of the parental, pseudo-
wild-type LACZ protein is indistinguishable from that of
the native enzyme (Table 1), the lack of the eight N-terminal
residues in LACZ makes this protein more sensitive to tem-
perature denaturation and proteolytic attack (Table 2).
4. Discussion
The identi¢cation of permissive sites for presentation of
foreign peptides has been achieved successfully in di¡erent
E. coli proteins, like LamB [30], MalE [31], lactose permease
[32], ClpG [33] and PhoE [34] among others. When using
enzymes, the insertion of functional protein segments o¡ers
an interesting approach for the design of new generation mo-
lecular sensors [35,36]. Because of the simplicity of its quanti-
tative analysis, E. coli L-galactosidase is one of the most ap-
propriate candidates as carrier framework for the construction
of multifunctional enzymes. However, empirical insertional
approaches have been barely successful in the identi¢cation
of tolerant acceptor sites [10,11]. By using crystallographic
coordinates [12] we have explored the tolerance to peptide
insertion of ¢ve selected unstructured segments of the E. coli
L-galactosidase, which we presumed to be su⁄ciently exposed,
far from the active site and from monomer-monomer interfa-
ces, to act as competent acceptors. The produced chimeric
monomers are stable in vivo, they fold correctly and associate
into active tetramers that can be puri¢ed by standard a⁄nity
chromatography. Moreover, on the surface of the assembled
enzyme, the inserted protein segment is recognised by an mAb
directed against an internal epitope, and it also interacts e⁄-
ciently with RGD-dependent cell surface integrins.
The introduction of peptides does not cause important al-
terations on the tertiary structure of the proteins (Table 2),
con¢rming the appropriate choice of the target loops. Protein
M278VP1, in which the enzymatic activity is signi¢cantly af-
fected, only shows a small shift of tryptophan £uorescence
peak (Table 2), that could represent a local destabilisation
of the enzyme in the activating interface. This observation is
in agreement with the lower enzymatic activity and stability of
this mutant (Tables 1 and 2). This region of E. coli L-galac-
tosidase (amino acids 271^287) extends from one monomer to
another forming the activating interface [12], and it was se-
lected on the basis of secondary structure predictions [15]. The
analysis of the insertional e¡ects con¢rms that this loop is
involved in critical monomer-monomer interactions.
The analysis of the mutant enzymes reveals that the posi-
tioning of the viral peptide has impairing e¡ects on substrate
processing (Table 1). Interestingly, JX772A and JX795A show
a higher a⁄nity for the ONPG than the wild-type protein
(note the lower Km values in Table 1, suggesting a higher
accessibility of the active site), eclipsed by a dramatic reduc-
tion in the hydrolysis rate. In mutants JX249A and JX581A,
L-galactosidase activity and stability are only moderately af-
fected. The unexpected trypsin sensitivity of JX581A is prob-
ably due to an e⁄cient presentation of a trypsin target site
present in the viral peptide [37,38], since the Western blot
analysis of trypsin-inactivated protein samples reveals two
stable protein fragments of 70 and 45 kDa, respectively (not
shown), compatible with a limited digestion at the insertion
site. It is worthy to stress that the peptide fusion at the C-
terminus (in JX8CA) and the lack of a short homologous N-
terminal peptide in the pseudo-wild type (LACZ) have dra-
matic e¡ects on the thermal stability of the enzyme (Table 2)
but little in£uence on the enzymatic activity. These results
reveal the participation of both protein termini in stabilising
the tetramer. The identi¢cation of 249 and 581 as permissive
insertion sites is a promising result for the generation of inser-
tional active mutants of E. coli L-galactosidase as the basis for
new molecular sensors.
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Fig. 2. A: Competition of recombinant L-galactosidases for mAb SD6, with the KLH-coupled synthetic peptide GH23 in indirect ELISA. The
same peptide has been included as a control of competing, soluble antigen. B: Binding of BHK cells to bound recombinant proteins. Absorb-
ances of stained cells are referred to that obtained with human vitronectin.
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